These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

179 related items for PubMed ID: 8934373

  • 21. Safety profile of lacidipine: a review of clinical data.
    Endersby CA, Brown EG, Perelman MS.
    J Cardiovasc Pharmacol; 1991; 17 Suppl 4():S45-7. PubMed ID: 1726006
    [Abstract] [Full Text] [Related]

  • 22. Comparative evaluation of the antihypertensive efficacy of once-daily sustained-release isradipine and lacidipine using 24-hour ambulatory blood-pressure monitoring.
    Galderisi M, Petrocelli A, Garofalo M, Celentano A, Alfieri A, de Divitiis O.
    J Int Med Res; 1995; 23(4):234-43. PubMed ID: 7589766
    [Abstract] [Full Text] [Related]

  • 23. A long-term study comparing lacidipine and nifedipine SR in hypertensive patients: safety data.
    Leonetti G, Salvi S.
    J Cardiovasc Pharmacol; 1994; 23 Suppl 5():S108-10. PubMed ID: 7609496
    [Abstract] [Full Text] [Related]

  • 24. A calcium antagonist vs a non-calcium antagonist hypertension treatment strategy for patients with coronary artery disease. The International Verapamil-Trandolapril Study (INVEST): a randomized controlled trial.
    Pepine CJ, Handberg EM, Cooper-DeHoff RM, Marks RG, Kowey P, Messerli FH, Mancia G, Cangiano JL, Garcia-Barreto D, Keltai M, Erdine S, Bristol HA, Kolb HR, Bakris GL, Cohen JD, Parmley WW, INVEST Investigators.
    JAMA; 2003 Dec 03; 290(21):2805-16. PubMed ID: 14657064
    [Abstract] [Full Text] [Related]

  • 25.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 26.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 27.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 28.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 29.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 30.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 31. The potential role of calcium antagonists in the management of congestive heart failure: initial experience with lacidipine.
    de Vries RJ, Dunselman PH.
    J Cardiovasc Pharmacol; 1995 Dec 03; 25 Suppl 3():S33-9. PubMed ID: 8852543
    [Abstract] [Full Text] [Related]

  • 32. Lercanidipine vs lacidipine in isolated systolic hypertension.
    Millar-Craig M, Shaffu B, Greenough A, Mitchell L, McDonald C.
    J Hum Hypertens; 2003 Nov 03; 17(11):799-806. PubMed ID: 14578921
    [Abstract] [Full Text] [Related]

  • 33. Prevalence and incidence of the metabolic syndrome in the European Lacidipine Study on Atherosclerosis (ELSA) and its relation with carotid intima-media thickness.
    Zanchetti A, Hennig M, Baurecht H, Tang R, Cuspidi C, Carugo S, Mancia G.
    J Hypertens; 2007 Dec 03; 25(12):2463-70. PubMed ID: 17984668
    [Abstract] [Full Text] [Related]

  • 34.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 35. Potential modification of plaque behavior through the European lacidipine study on atherosclerosis.
    Bond MG, Mercuri M.
    J Cardiovasc Pharmacol; 1995 Dec 03; 25 Suppl 3():S11-6. PubMed ID: 8852539
    [Abstract] [Full Text] [Related]

  • 36.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 37. Manidipine versus enalapril monotherapy in patients with hypertension and type 2 diabetes mellitus: a multicenter, randomized, double-blind, 24-week study.
    Luque Otero M, Martell Claros N, Study Investigators Group.
    Clin Ther; 2005 Feb 03; 27(2):166-73. PubMed ID: 15811479
    [Abstract] [Full Text] [Related]

  • 38. Effects of blood pressure-lowering treatment on cardiovascular outcomes and mortality: 14 - effects of different classes of antihypertensive drugs in older and younger patients: overview and meta-analysis.
    Thomopoulos C, Parati G, Zanchetti A.
    J Hypertens; 2018 Aug 03; 36(8):1637-1647. PubMed ID: 29847487
    [Abstract] [Full Text] [Related]

  • 39.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 40. Dihydropyridine calcium channel antagonists in the management of hypertension.
    Epstein BJ, Vogel K, Palmer BF.
    Drugs; 2007 Aug 03; 67(9):1309-27. PubMed ID: 17547473
    [Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 9.